Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enterol in Child-Pugh B and C cirrhosis
NCT05231772Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of piromidic acid in Cirrhosis, sponsored by Sechenov First Moscow State Medical University. Primary endpoint: cardiac output at 12 weeks. Started Mar 2021; status: completed.
02
Drugs
piromidic acid
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NCT05231772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05231772.